1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report

Summary

The Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Antisense and RNAi Therapeutics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Antisense and RNAi Therapeutics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Antisense and RNAi Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 172 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Antisense and RNAi Therapeutics
1.1.1 Definition of Antisense and RNAi Therapeutics
1.1.2 Specifications of Antisense and RNAi Therapeutics
1.2 Classification of Antisense and RNAi Therapeutics
1.3 Applications of Antisense and RNAi Therapeutics
1.4 Industry Chain Structure of Antisense and RNAi Therapeutics
1.5 Industry Overview and Major Regions Status of Antisense and RNAi Therapeutics
1.5.1 Industry Overview of Antisense and RNAi Therapeutics
1.5.2 Global Major Regions Status of Antisense and RNAi Therapeutics
1.6 Industry Policy Analysis of Antisense and RNAi Therapeutics
1.7 Industry News Analysis of Antisense and RNAi Therapeutics

2 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
2.1 Raw Material Suppliers and Price Analysis of Antisense and RNAi Therapeutics
2.2 Equipment Suppliers and Price Analysis of Antisense and RNAi Therapeutics
2.3 Labor Cost Analysis of Antisense and RNAi Therapeutics
2.4 Other Costs Analysis of Antisense and RNAi Therapeutics
2.5 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
2.6 Manufacturing Process Analysis of Antisense and RNAi Therapeutics
2.7 Global Price, Cost and Gross of Antisense and RNAi Therapeutics 2010-2015

3 Technical Data and Manufacturing Plants Analysis of Antisense and RNAi Therapeutics
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Antisense and RNAi Therapeutics Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014

4 Production Analysis of Antisense and RNAi Therapeutics by Regions, Type, and Applications
4.1 Global Production of Antisense and RNAi Therapeutics by Regions 2010-2015
4.2 Global Production of Antisense and RNAi Therapeutics by Type 2010-2015
4.3 Global Production of Antisense and RNAi Therapeutics by Applications 2010-2015
4.4 Price Analysis of Global Antisense and RNAi Therapeutics Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
4.6 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
4.7 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
4.8 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015

5 Consumption Volume and Consumption Value Analysis of Antisense and RNAi Therapeutics by Regions
5.1 Global Consumption Volume of Antisense and RNAi Therapeutics by Regions 2010-2015
5.2 Global Consumption Value of Antisense and RNAi Therapeutics by Regions 2010-2015
5.3 Global Consumption Price Analysis of Antisense and RNAi Therapeutics by Regions 2010-2015

6 Analysis of Antisense and RNAi Therapeutics Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Antisense and RNAi Therapeutics 2010-2015
6.2 Production Market Share Analysis of Antisense and RNAi Therapeutics 2010-2015
6.3 Sales Overview of Antisense and RNAi Therapeutics 2010-2015
6.4 Supply, Sales and Gap of Antisense and RNAi Therapeutics 2010-2015
6.5 Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Antisense and RNAi Therapeutics 2010-2015

7 Analysis of Antisense and RNAi Therapeutics Industry Key Manufacturers
7.1 Alnylam Pharmaceuticals
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Contact Information

7.2 Isis Pharmaceuticals
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Contact Information

7.3 Sanofi SA
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Contact Information

7.4 Tekmira Pharmaceuticals
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Contact Information

8 Price and Gross Margin Analysis of Antisense and RNAi Therapeutics
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Antisense and RNAi Therapeutics Product Types
8.5 Market Share Analysis of Different Antisense and RNAi Therapeutics Price Levels
8.6 Gross Margin Analysis of Different Antisense and RNAi Therapeutics Applications

9 Marketing Trader or Distributor Analysis of Antisense and RNAi Therapeutics
9.1 Marketing Channels Status of Antisense and RNAi Therapeutics
9.2 Traders or Distributors of Antisense and RNAi Therapeutics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Antisense and RNAi Therapeutics
9.4 Regional Import, Export and Trade Analysis of Antisense and RNAi Therapeutics

10 Development Trend of Antisense and RNAi Therapeutics Industry 2016-2021
10.1 Capacity and Production Overview of Antisense and RNAi Therapeutics 2016-2021
10.2 Production Market Share Analysis of Antisense and RNAi Therapeutics 2016-2021
10.3 Sales Overview of Antisense and RNAi Therapeutics 2016-2021
10.4 Supply, Sales, and Gap of Antisense and RNAi Therapeutics 2016-2021
10.5 Import, Export and Consumption of Antisense and RNAi Therapeutics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Antisense and RNAi Therapeutics 2016-2021

11 Industry Chain Suppliers with Contact Information of Antisense and RNAi Therapeutics
11.1 Major Raw Materials Suppliers with Contact Information of Antisense and RNAi Therapeutics Industry
11.2 Manufacturing Equipment Suppliers of Antisense and RNAi Therapeutics with Contact Information
11.3 Major Suppliers of Antisense and RNAi Therapeutics with Contact Information
11.4 Key Consumers of Antisense and RNAi Therapeutics with Contact Information
11.5 Supply Chain Relationship Analysis of Antisense and RNAi Therapeutics

12 New Project Investment Feasibility Analysis of Antisense and RNAi Therapeutics
12.1 New Project SWOT Analysis of Antisense and RNAi Therapeutics
12.2 New Project Investment Feasibility Analysis of Antisense and RNAi Therapeutics

13 Conclusion of the Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report


List of Tables and Figures
Figure Picture of Antisense and RNAi Therapeutics
Table Specifications of Antisense and RNAi Therapeutics
Table Classification of Antisense and RNAi Therapeutics
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Type in 2015
Table Application Fields of Antisense and RNAi Therapeutics Products
Figure 2015 Global Antisense and RNAi Therapeutics Major Applications Sales Share
Figure Industry Chain Structure of Antisense and RNAi Therapeutics
Table Global Major Regions Antisense and RNAi Therapeutics Development Status
Table Industry Policy of Antisense and RNAi Therapeutics
Table Industry News List of Antisense and RNAi Therapeutics
Table Antisense and RNAi Therapeutics Major Raw Materials List
Table Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics in 2014
Figure Manufacturing Process Analysis of Antisense and RNAi Therapeutics
Figure Global Price Analysis of Antisense and RNAi Therapeutics 2010-2015 (USD/Dose)
Figure Global Cost Analysis of Antisense and RNAi Therapeutics 2010-2015 (USD/Dose)
Figure Global Gross Analysis of Antisense and RNAi Therapeutics 2010-2015
Table Capacity (Dose) and Commercial Production Date of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Antisense and RNAi Therapeutics Manufacturers in 2014
Table RandD Status and Technology Source of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Antisense and RNAi Therapeutics Key Manufacturers in 2014
Table Global Production of Antisense and RNAi Therapeutics by Regions 2010-2015 (Dose)
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2014
Table Global Production of Antisense and RNAi Therapeutics by Type 2010-2015 (Dose)
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Type in 2014
Table Global Production of Antisense and RNAi Therapeutics by Applications 2010-2015 (Dose)
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2014
Figure Price Comparison of Global Antisense and RNAi Therapeutics Key Manufacturers in 2015 (USD/Dose)
Table US Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Table US Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table EU Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Table EU Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Japan Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Table Japan Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table China Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Table China Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Global Consumption Volume of Antisense and RNAi Therapeutics by Regions 2010-2015 (Dose)
Figure Global Consumption Volume of Antisense and RNAi Therapeutics by Regions in 2010 (Dose)
Figure Global Consumption Volume of Antisense and RNAi Therapeutics by Regions in 2011 (Dose)
Figure Global Consumption Volume of Antisense and RNAi Therapeutics by Regions in 2012 (Dose)
Figure Global Consumption Volume of Antisense and RNAi Therapeutics by Regions in 2013 (Dose)
Figure Global Consumption Volume of Antisense and RNAi Therapeutics by Regions in 2014 (Dose)
Figure Global Consumption Volume of Antisense and RNAi Therapeutics by Regions in 2015 (Dose)
Table Global Consumption Value of Antisense and RNAi Therapeutics by Regions 2010-2015 (M USD)
Figure Global Consumption Value of Antisense and RNAi Therapeutics by Regions in 2010 (M USD)
Figure Global Consumption Value of Antisense and RNAi Therapeutics by Regions in 2011 (M USD)
Figure Global Consumption Value of Antisense and RNAi Therapeutics by Regions in 2012 (M USD)
Figure Global Consumption Value of Antisense and RNAi Therapeutics by Regions in 2013 (M USD)
Figure Global Consumption Value of Antisense and RNAi Therapeutics by Regions in 2014 (M USD)
Figure Global Consumption Value of Antisense and RNAi Therapeutics by Regions in 2015 (M USD)
Table Consumption Price of Antisense and RNAi Therapeutics by Regions 2010-2015 (USD/Dose)
Table Global and Major Manufacturers Capacity of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Global Capacity Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure Global Capacity (Dose), Production (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure Global Capacity Utilization Rate of Antisense and RNAi Therapeutics 2010-2015
Table Global and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Table China and Major Manufacturers Capacity of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Capacity Market Share of China Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Table China and Major Manufacturers Production of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Production Market Share of China Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure China Capacity (Dose), Production (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure China Capacity Utilization Rate of Antisense and RNAi Therapeutics 2010-2015
Table China and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2010
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2011
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2012
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2013
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2014
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2015
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2010
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2011
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2012
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2013
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2014
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2015
Figure Global Sales (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure China Sales (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Table Global Supply, Sales and Gap of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table China Supply, Sales and Gap of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table China Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (Dose)
Table Price of Global Antisense and RNAi Therapeutics Major Manufacturers 2010-2015 (USD/Dose)
Figure Price Comparison by Global Major Antisense and RNAi Therapeutics Manufacturers in 2014 (USD/Dose)
Table Gross Margin of Global Antisense and RNAi Therapeutics Major Manufacturers 2010-2015
Figure Gross Margin of Global Antisense and RNAi Therapeutics Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2011
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2012
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2013
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2014
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2015
Table China and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Antisense and RNAi Therapeutics Major Manufacturers 2010-2015
Table Global Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Table China Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Figure Antisense and RNAi Therapeutics Picture and Specifications of Alnylam Pharmaceuticals
Table Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose) and Growth Rate of Alnylam Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Production (Dose) and Global Market Share of Alnylam Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Picture and Specifications of Isis Pharmaceuticals
Table Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Isis Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose) and Growth Rate of Isis Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Production (Dose) and Global Market Share of Isis Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Picture and Specifications of Sanofi SA
Table Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi SA 2010-2015
Figure Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose) and Growth Rate of Sanofi SA 2010-2015
Figure Antisense and RNAi Therapeutics Production (Dose) and Global Market Share of Sanofi SA 2010-2015
Figure Antisense and RNAi Therapeutics Picture and Specifications of Tekmira Pharmaceuticals
Table Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Tekmira Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Capacity (Dose), Production (Dose) and Growth Rate of Tekmira Pharmaceuticals 2010-2015
Figure Antisense and RNAi Therapeutics Production (Dose) and Global Market Share of Tekmira Pharmaceuticals 2010-2015
Table Gross Margin of Antisense and RNAi Therapeutics by Regions 2010-2015
Table Price Comparison of Antisense and RNAi Therapeutics by Regions 2010-2015 (USD/Dose)
Table Price of Different Antisense and RNAi Therapeutics Product Types (USD/Dose)
Table Market Share of Different Antisense and RNAi Therapeutics Price Level
Table Gross Margin of Different Antisense and RNAi Therapeutics Applications
Table Traders or Distributors of Antisense and RNAi Therapeutics with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Antisense and RNAi Therapeutics (USD/Dose)
Table Regional Import, Export, and Trade of Antisense and RNAi Therapeutics (Dose)
Figure Global Capacity (Dose), Production (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2016-2021
Figure Global Capacity Utilization Rate of Antisense and RNAi Therapeutics 2016-2021
Figure China Capacity (Dose), Production (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2016-2021
Figure China Capacity Utilization Rate of Antisense and RNAi Therapeutics 2016-2021
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2016
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2021
Figure Production Market Share of China Major Antisense and RNAi Therapeutics Manufacturers in 2016
Figure Production Market Share of China Major Antisense and RNAi Therapeutics Manufacturers in 2021
Figure Global and China Sales (Dose) and Growth Rate of Antisense and RNAi Therapeutics 2016-2021
Table Global Supply, Sales and Gap of Antisense and RNAi Therapeutics 2016-2021 (Dose)
Table China Supply, Sales and Gap of Antisense and RNAi Therapeutics 2016-2021 (Dose)
Table China Production, Import, Export and Consumption of Antisense and RNAi Therapeutics 2016-2021 (Dose)
Table Global Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2016-2021
Table China Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2016-2021
Table Major Raw Materials Suppliers with Contact Information of Antisense and RNAi Therapeutics
Table Manufacturing Equipment Suppliers of Antisense and RNAi Therapeutics with Contact Information
Table Major Suppliers of Antisense and RNAi Therapeutics with Contact Information
Table Key Consumers of Antisense and RNAi Therapeutics with Contact Information
Figure Supply Chain Relationship Analysis of Antisense and RNAi Therapeutics
Table New Project SWOT Analysis of Antisense and RNAi Therapeutics
Table New Project Investment Feasibility Analysis of Antisense and RNAi Therapeutics
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • $ 6650
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. ...

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.